Robert Burns
Stock Analyst at HC Wainwright & Co.
(0.90)
# 3,647
Out of 4,829 analysts
497
Total ratings
23.75%
Success rate
-22.52%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Maintains: Buy | $21 → $22 | $5.08 | +333.07% | 24 | May 9, 2025 | |
| CRDF Cardiff Oncology | Maintains: Buy | $17 → $18 | $2.66 | +576.69% | 2 | May 9, 2025 | |
| PRLD Prelude Therapeutics | Reiterates: Buy | $5 | $0.80 | +523.36% | 16 | May 5, 2025 | |
| SWTX SpringWorks Therapeutics | Downgrades: Neutral | $74 → $47 | $46.26 | +1.60% | 32 | Apr 30, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $9 → $3 | $0.77 | +287.45% | 14 | Apr 28, 2025 | |
| TNGX Tango Therapeutics | Reiterates: Buy | $13 | $1.14 | +1,040.35% | 12 | Apr 14, 2025 | |
| BCAX Bicara Therapeutics | Maintains: Buy | $45 → $44 | $12.97 | +239.24% | 3 | Apr 7, 2025 | |
| HURA TuHURA Biosciences | Maintains: Buy | $13 → $12 | $3.99 | +200.75% | 2 | Apr 3, 2025 | |
| NRIX Nurix Therapeutics | Reiterates: Buy | $36 | $9.50 | +278.95% | 15 | Apr 2, 2025 | |
| ELTX Elicio Therapeutics | Reiterates: Buy | $10 | $5.49 | +82.15% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $92.87 | +56.14% | 38 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.27 | +529.92% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.35 | +325.53% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $36.17 | +10.59% | 7 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.43 | +39.86% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $12 | $3.89 | +208.48% | 20 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $39 | $18.42 | +111.73% | 3 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.88 | +466.57% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.16 | +589.66% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $1.64 | +631.71% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $1.90 | +1,689.47% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $13 | $11.31 | +14.99% | 20 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.09 | +378.47% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.35 | +270.37% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.00 | +433.33% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $39 | $20.15 | +93.55% | 8 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $72 → $73 | $40.42 | +80.60% | 19 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $7.71 | +185.34% | 16 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.09 | +234.93% | 7 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.03 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $7.31 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $4.81 | +191.06% | 10 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.13 | +873.45% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $2.25 | $0.72 | +211.81% | 10 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.49 | +3,542.99% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.46 | +4,258.25% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.18 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.32 | +6,365.52% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.13 | +1,846.90% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.04 | +573.08% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $0.93 | +1,084.83% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.04 | +535,614.29% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.05 | +517.28% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.32 | +884.85% | 1 | Jan 7, 2021 |
ORIC Pharmaceuticals
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $5.08
Upside: +333.07%
Cardiff Oncology
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $2.66
Upside: +576.69%
Prelude Therapeutics
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.80
Upside: +523.36%
SpringWorks Therapeutics
Apr 30, 2025
Downgrades: Neutral
Price Target: $74 → $47
Current: $46.26
Upside: +1.60%
Caribou Biosciences
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $0.77
Upside: +287.45%
Tango Therapeutics
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $1.14
Upside: +1,040.35%
Bicara Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $45 → $44
Current: $12.97
Upside: +239.24%
TuHURA Biosciences
Apr 3, 2025
Maintains: Buy
Price Target: $13 → $12
Current: $3.99
Upside: +200.75%
Nurix Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $9.50
Upside: +278.95%
Elicio Therapeutics
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $5.49
Upside: +82.15%
Apr 1, 2025
Maintains: Buy
Price Target: $150 → $145
Current: $92.87
Upside: +56.14%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $1.27
Upside: +529.92%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $2.35
Upside: +325.53%
Mar 27, 2025
Reiterates: Buy
Price Target: $40
Current: $36.17
Upside: +10.59%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.43
Upside: +39.86%
Mar 21, 2025
Maintains: Buy
Price Target: $22 → $12
Current: $3.89
Upside: +208.48%
Mar 21, 2025
Maintains: Buy
Price Target: $37 → $39
Current: $18.42
Upside: +111.73%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $0.88
Upside: +466.57%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.16
Upside: +589.66%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $1.64
Upside: +631.71%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $1.90
Upside: +1,689.47%
Mar 10, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $11.31
Upside: +14.99%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.09
Upside: +378.47%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.35
Upside: +270.37%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.00
Upside: +433.33%
Mar 7, 2025
Reiterates: Buy
Price Target: $39
Current: $20.15
Upside: +93.55%
Mar 3, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $40.42
Upside: +80.60%
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $7.71
Upside: +185.34%
Feb 10, 2025
Reiterates: Buy
Price Target: $7
Current: $2.09
Upside: +234.93%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.03
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $7.31
Upside: -
Jan 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $4.81
Upside: +191.06%
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.13
Upside: +873.45%
Aug 19, 2024
Reiterates: Buy
Price Target: $2.25
Current: $0.72
Upside: +211.81%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.49
Upside: +3,542.99%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.46
Upside: +4,258.25%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.18
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.32
Upside: +6,365.52%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.13
Upside: +1,846.90%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.04
Upside: +573.08%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $0.93
Upside: +1,084.83%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.04
Upside: +535,614.29%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.05
Upside: +517.28%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.32
Upside: +884.85%